Pluri (PLUR) Operating Leases (2019 - 2025)
Pluri (PLUR) posted quarterly Operating Leases of $6.1 million for Q4 2025, up 25.31% year-over-year from $4.9 million in Q4 2024, and up 1.91% quarter-over-quarter from $6.0 million in Q3 2025.
Pluri (PLUR) Operating Leases (2019 - 2025) Analysis & Trends
Pluri (PLUR) has reported Operating Leases for 7 consecutive years, with $6.1 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Operating Leases rose 25.31% year-over-year to $6.1 million; the TTM figure through Dec 2025 stood at $6.1 million (up 25.31% YoY), while the FY2025 annual figure was $6.1 million, up 21.41% from the prior year.
- Operating Leases advanced to $6.1 million in Q4 2025 per PLUR's latest filing, from $6.0 million in the prior quarter.
- Across five years, Operating Leases topped out at $7.6 million in Q4 2021 and bottomed at $94000.0 in Q3 2021.
- Historically, Operating Leases has averaged $5.1 million across 5 years, with a median of $5.7 million in 2023.
- Annual changes were most pronounced in 2021 — Operating Leases plunged 82.3% — and 2022, when it jumped 7024.0%.
- Pluri's Operating Leases stood at $7.6 million in 2021, then retreated by 18.03% to $6.2 million in 2022, then retreated by 13.4% to $5.4 million in 2023, then decreased by 9.25% to $4.9 million in 2024, then grew by 25.31% to $6.1 million in 2025.
- Business Quant data shows PLUR's Operating Leases at $6.1 million in Q4 2025, $6.0 million in Q3 2025, and $6.1 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.61 Bn | 131.75 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.70 Bn | 78.71 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.28 Bn | 60.09 Bn | 1.37 Bn |
| 4 | Moderna | 59.14 Bn | 54.00 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.13 Bn | 37.03 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.83 Bn | 28.52 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.07 Bn | 9.68 Bn | 668.28 Mn |
| 8 | Insmed | 27.54 Bn | 26.38 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - |
| 10 | Pluri | 15.74 Mn | 3.26 Mn | 86,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.14 Mn |
| Sep 30, 2025 | 6.03 Mn |
| Jun 30, 2025 | 6.10 Mn |
| Mar 31, 2025 | 5.64 Mn |
| Dec 31, 2024 | 4.90 Mn |
| Sep 30, 2024 | 4.94 Mn |
| Jun 30, 2024 | 5.03 Mn |
| Mar 31, 2024 | 5.34 Mn |
| Dec 31, 2023 | 5.40 Mn |
| Sep 30, 2023 | 5.43 Mn |
| Jun 30, 2023 | 5.75 Mn |
| Mar 31, 2023 | 6.03 Mn |
| Dec 31, 2022 | 6.24 Mn |
| Sep 30, 2022 | 6.30 Mn |
| Jun 30, 2022 | 7.12 Mn |
| Mar 31, 2022 | 7.27 Mn |
| Dec 31, 2021 | 7.61 Mn |
| Sep 30, 2021 | 94,000.00 |
| Jun 30, 2021 | 100,000.00 |
| Mar 31, 2021 | 169,000.00 |